Literature DB >> 11591833

In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy.

R C Knowlton1, K D Laxer, G Klein, S Sawrie, G Ende, R A Hawkins, O S Aassar, K Soohoo, S Wong, N Barbaro.   

Abstract

BACKGROUND: The appearance of decreased 2-[(18)F]fluoro-2-deoxy-D-glucose (FDG) uptake in the mesial temporal region in temporal lobe epilepsy may simply reflect loss of gray matter due to hippocampal atrophy. Increased partial volume effects due to atrophic hippocampi may further increase appearance of hypometabolism.
METHODS: The authors used a combination of MRI-PET coregistration, with MRI-based gray matter segmentation, and partial volume correction to improve the examination of hippocampal specific glucose uptake in FDG PET. The goal was to determine 1) if relative mesial temporal hypometabolism is an artifact of gray matter (hippocampal) atrophy, 2) whether hippocampal metabolism correlates with atrophy evaluated on MRI, and 3) if MRI-based partial volume correction influences measurement of hippocampal metabolic-volume relationships, including epilepsy lateralization.
RESULTS: Findings showed that ipsilateral hippocampi of mesial temporal lobe epilepsy (MTLE) are relatively hypometabolic per unit of gray matter volume, and that hippocampal metabolism directly correlates with hippocampal volume. Specifically, partial volume corrected hippocampal metabolism correlated strongly (r = 0.613, p < 0.001) with hippocampal volume. Without partial volume correction, a weaker, but still significant, correlation was present (r = 0.482, p < 0.001). Degree of asymmetry was consistently greater and provided higher sensitivity of lateralization with partial volume vs non-partial volume corrected metabolic measurements.
CONCLUSIONS: Although, decreased metabolism may occur in the absence of neuronal cell loss, hippocampal atrophy and presumed degree of neuronal cell loss appears to be a primary factor involved in the cause of decreased metabolism in epileptogenic hippocampi. Partial volume correction is recommended for optimal interpretation of hippocampal structure and function relationships.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591833     DOI: 10.1212/wnl.57.7.1184

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Distinguishing Lateral Temporal Neocortical and Mesial Temporal Lobe Epilepsy.

Authors:  William H Theodore
Journal:  Epilepsy Curr       Date:  2004-03       Impact factor: 7.500

2.  5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction.

Authors:  Giampiero Giovacchini; Maria T Toczek; Robert Bonwetsch; Anto Bagic; Lixin Lang; Charles Fraser; Pat Reeves-Tyer; Peter Herscovitch; William C Eckelman; Richard E Carson; William H Theodore
Journal:  J Nucl Med       Date:  2005-07       Impact factor: 10.057

3.  Anatomy-based reconstruction of FDG-PET images with implicit partial volume correction improves detection of hypometabolic regions in patients with epilepsy due to focal cortical dysplasia diagnosed on MRI.

Authors:  Karolien Goffin; Wim Van Paesschen; Patrick Dupont; Kristof Baete; André Palmini; Johan Nuyts; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-20       Impact factor: 9.236

4.  Cerebral blood flow in temporal lobe epilepsy: a partial volume correction study.

Authors:  Giampiero Giovacchini; Robert Bonwetsch; Peter Herscovitch; Richard E Carson; William H Theodore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-01       Impact factor: 9.236

5.  The evaluation of FDG-PET imaging for epileptogenic focus localization in patients with MRI positive and MRI negative temporal lobe epilepsy.

Authors:  Beril Gok; George Jallo; Reza Hayeri; Richard Wahl; Nafi Aygun
Journal:  Neuroradiology       Date:  2012-12-08       Impact factor: 2.804

Review 6.  Neuroimaging biomarkers for epilepsy: advances and relevance to glial cells.

Authors:  Andre Obenaus
Journal:  Neurochem Int       Date:  2013-05-09       Impact factor: 3.921

Review 7.  The hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia.

Authors:  Charles B Mikell; Guy M McKhann; Solomon Segal; Robert A McGovern; Matthew B Wallenstein; Holly Moore
Journal:  Stereotact Funct Neurosurg       Date:  2009-06-26       Impact factor: 1.875

8.  Seizure outcomes in relation to the extent of resection of the perifocal fluorodeoxyglucose and flumazenil PET abnormalities in anteromedial temporal lobectomy.

Authors:  Milo Stanišić; Christopher Coello; Jugoslav Ivanović; Arild Egge; Torsten Danfors; John Hald; Einar Heminghyt; Marjan Makki Mikkelsen; Bård Kronen Krossnes; Are Hugo Pripp; Pål Gunnar Larsson
Journal:  Acta Neurochir (Wien)       Date:  2015-09-08       Impact factor: 2.216

9.  Déjà experiences in temporal lobe epilepsy.

Authors:  Nathan A Illman; Chris R Butler; Celine Souchay; Chris J A Moulin
Journal:  Epilepsy Res Treat       Date:  2012-03-20

10.  Use of an Automated Quantitative Analysis of Hippocampal Volume, Signal, and Glucose Metabolism to Detect Hippocampal Sclerosis.

Authors:  Wen-Han Hu; Li-Na Liu; Bao-Tian Zhao; Xiu Wang; Chao Zhang; Xiao-Qiu Shao; Kai Zhang; Yan-Shan Ma; Lin Ai; Jun-Ju Li; Jian-Guo Zhang
Journal:  Front Neurol       Date:  2018-10-04       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.